Potentiation of doxorubicin cytotoxicity by the calcium antagonist bepridil in anthracycline-resistant and -sensitive cell lines. A comparison with verapamil. (Q54415300)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Potentiation of doxorubicin cytotoxicity by the calcium antagonist bepridil in anthracycline-resistant and -sensitive cell lines. A comparison with verapamil.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/3500807

Potentiation of doxorubicin cytotoxicity by the calcium antagonist bepridil in anthracycline-resistant and -sensitive cell lines. A comparison with verapamil. (English)

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/3500807

0 references

1 reference

based on heuristic

inferred from title

author name string

G J Schuurhuis

1

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/3500807

H J Broxterman

2

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/3500807

J J van der Hoeven

3

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/3500807

H M Pinedo

4

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/3500807

J Lankelma

5

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/3500807

publication date

1 January 1987

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/3500807

Cancer Chemotherapy and Pharmacology

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/3500807

20

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/3500807

4

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/3500807

285-290

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/3500807

Adriamycin accumulation and metabolism in adriamycin-sensitive and -resistant human ovarian cancer cell lines

1 reference

https://pubmed.ncbi.nlm.nih.gov/3500807

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacologic reversal of drug resistance in ovarian cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/3500807

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Circumvention of vincristine and Adriamycin resistance in vitro and in vivo by calcium influx blockers.

1 reference

https://pubmed.ncbi.nlm.nih.gov/3500807

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetics and metabolism of bepridil

1 reference

https://pubmed.ncbi.nlm.nih.gov/3500807

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Increased accumulation of vincristine and adriamycin in drug-resistant P388 tumor cells following incubation with calcium antagonists and calmodulin inhibitors.

1 reference

https://pubmed.ncbi.nlm.nih.gov/3500807

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Experimental therapeutics and kinetics: selection and overgrowth of specifically and permanently drug-resistant tumor cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/3500807

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Potentiation of vincristine and Adriamycin effects in human hemopoietic tumor cell lines by calcium antagonists and calmodulin inhibitors.

1 reference

https://pubmed.ncbi.nlm.nih.gov/3500807

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase I study of vinblastine and verapamil given by concurrent iv infusion

1 reference

https://pubmed.ncbi.nlm.nih.gov/3500807

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Verapamil Restoration of Daunorubicin Responsiveness in Daunorubicin-resistant Ehrlich Ascites Carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/3500807

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reversal of acquired resistance to vinca alkaloids and anthracycline antibiotics

1 reference

https://pubmed.ncbi.nlm.nih.gov/3500807

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The calcium channel blocker verapamil and cancer chemotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/3500807

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Overcoming of vincristine resistance in P388 leukemia in vivo and in vitro through enhanced cytotoxicity of vincristine and vinblastine by verapamil

1 reference

https://pubmed.ncbi.nlm.nih.gov/3500807

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of verapamil on daunomycin cellular retention and cytotoxicity in P388 leukemic cells.

1 reference

https://pubmed.ncbi.nlm.nih.gov/3500807

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Verapamil potentiation of VP-16-213 in acute lymphatic leukemia and reversal of pleiotropic drug resistance.

1 reference

https://pubmed.ncbi.nlm.nih.gov/3500807

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reversal of Adriamycin Resistance by Verapamil in Human Ovarian Cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/3500807

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reversal of Vinca alkaloid resistance but not multiple drug resistance in human leukemic cells by verapamil

1 reference

https://pubmed.ncbi.nlm.nih.gov/3500807

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Calcium Channel Blocker Enhancement of Anticancer Drug Cytotoxicity—A Review

1 reference

https://pubmed.ncbi.nlm.nih.gov/3500807

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/BF00262578

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/3500807

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/3500807

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54415300&oldid=2212459096"